Indecainide

Summary

Indecainide (CHEMBL1201242) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 308.4 Da · C20H24N2O

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201242
Name	Indecainide
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	52195
Molecular formula	C20H24N2O
Molecular weight	308.4
InChIKey	UCEWGESNIULAGX-UHFFFAOYSA-N

SMILES: CC(C)NCCCC1(C2=CC=CC=C2C3=CC=CC=C31)C(=O)N

IUPAC name: 9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide

Also known as: Indecainida, Indecainide, SID170465192, INDECAINIDE

Parent form; salt/anhydrous children: CHEMBL1200341

Patent coverage: 226 distinct patent families (745 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No CPIC/DPWG dosing guideline or drug-level clinical/variant annotations in PharmGKB for this molecule.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).